MUSCLE-INVASIVE BLADDER CARCINOMA
Clinical trials for MUSCLE-INVASIVE BLADDER CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new MUSCLE-INVASIVE BLADDER CARCINOMA trials appear
Sign up with your email to follow new studies for MUSCLE-INVASIVE BLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo attack on rare bladder cancer shows promise in early trial
Disease control CompletedThis pilot study tested whether giving the immunotherapy drug pembrolizumab together with standard chemotherapy before surgery could help people with rare forms of muscle-invasive bladder cancer. The 17 participants had cancer that had spread into the bladder muscle but not to ot…
Matched conditions: MUSCLE-INVASIVE BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 26, 2026 06:25 UTC
-
New hope for bladder cancer patients ineligible for chemo
Disease control CompletedThis early-phase study tested a combination of two drugs—CG0070 (given directly into the bladder) and nivolumab (given through a vein)—in 21 people with muscle-invasive bladder cancer who could not receive the standard chemotherapy drug cisplatin. The main goal was to check safet…
Matched conditions: MUSCLE-INVASIVE BLADDER CARCINOMA
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 26, 2026 06:14 UTC
-
Bladder cancer trail: DNA in blood and urine may predict treatment success
Knowledge-focused CompletedThis small pilot study looked at whether DNA from cancer cells (called ctDNA) can be detected in the blood or urine of people with muscle-invasive bladder cancer who are receiving a combination of surgery, radiation, and chemotherapy. The goal was to see if collecting and measuri…
Matched conditions: MUSCLE-INVASIVE BLADDER CARCINOMA
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC